Helgadóttir H - Search Results

1

Predictors of Gastrin Elevation Following Proton Pump Inhibitor Therapy.

Helgadóttir H, Lund SH, Gizurarson S, Metz DC, Björnsson ES. Helgadóttir H, et al. J Clin Gastroenterol. 2020 Mar;54(3):227-234. doi: 10.1097/MCG.0000000000001200. J Clin Gastroenterol. 2020. PMID: 30994520 Free PMC article.

2

The effects of long-term therapy with proton pump inhibitors on meal stimulated gastrin.

Helgadóttir H, Metz DC, Yang YX, Rhim AD, Björnsson ES. Helgadóttir H, et al. Dig Liver Dis. 2014 Feb;46(2):125-30. doi: 10.1016/j.dld.2013.09.021. Epub 2013 Nov 6. Dig Liver Dis. 2014. PMID: 24210828

3

Study of Gender Differences in Proton Pump Inhibitor Dose Requirements for GERD: A Double-Blind Randomized Trial.

Helgadóttir H, Metz DC, Lund SH, Gizurarson S, Jacobsen EI, Asgeirsdóttir GA, Yngadóttir Y, Björnsson ES. Helgadóttir H, et al. J Clin Gastroenterol. 2017 Jul;51(6):486-493. doi: 10.1097/MCG.0000000000000542. J Clin Gastroenterol. 2017. PMID: 27159420 Clinical Trial.

4

Problems Associated with Deprescribing of Proton Pump Inhibitors.

Helgadottir H, Bjornsson ES. Helgadottir H, et al. Int J Mol Sci. 2019 Nov 2;20(21):5469. doi: 10.3390/ijms20215469. Int J Mol Sci. 2019. PMID: 31684070 Free PMC article. Review.

5

Pharmacokinetics of single and repeated oral doses of esomeprazole and gastrin elevation in healthy males and females.

Helgadóttir H, Lund SH, Gizurarson S, Waldum H, Björnsson ES. Helgadóttir H, et al. Scand J Gastroenterol. 2021 Feb;56(2):128-136. doi: 10.1080/00365521.2020.1859610. Epub 2020 Dec 17. Scand J Gastroenterol. 2021. PMID: 33327801

6

Population pharmacokinetics of esomeprazole in patients with preterm preeclampsia.

Gebreyesus MS, Decloedt EH, Cluver CA, Hunfeld NGM, Helgadóttir H, Björnsson ES, Wasmann RE, Denti P. Gebreyesus MS, et al. Among authors: helgadottir h. Br J Clin Pharmacol. 2022 Oct;88(10):4639-4645. doi: 10.1111/bcp.15416. Epub 2022 Jun 3. Br J Clin Pharmacol. 2022. PMID: 35599445 Free article.

7

[Current use of proton pump inhibitors and when to limit, stop or not start treatment].

Helgadottir H, Bjornsson ES. Helgadottir H, et al. Laeknabladid. 2023 Jul;109(708):338-345. doi: 10.17992/lbl.2023.0708.752. Laeknabladid. 2023. PMID: 37378651 Free article. Icelandic.

8

Improvement of cholestatic episodes in patients with benign recurrent intrahepatic cholestasis (BRIC) treated with rifampicin. A long-term follow-up.

Helgadottir H, Folvik G, Vesterhus M. Helgadottir H, et al. Scand J Gastroenterol. 2023 May;58(5):512-520. doi: 10.1080/00365521.2022.2143725. Epub 2022 Nov 11. Scand J Gastroenterol. 2023. PMID: 36369734

9

Fertility and reproductive concerns related to the new generation of cancer drugs and the clinical implication for young individuals undergoing treatments for solid tumors.

Helgadottir H, Matikas A, Fernebro J, Frödin JE, Ekman S, Rodriguez-Wallberg KA. Helgadottir H, et al. Eur J Cancer. 2024 May;202:114010. doi: 10.1016/j.ejca.2024.114010. Epub 2024 Mar 11. Eur J Cancer. 2024. PMID: 38520926 Free article. Review.

10

Survival and Quality of Life after Isolated Hepatic Perfusion with Melphalan as a Treatment for Uveal Melanoma Liver Metastases - Final Results from the Phase III Randomized Controlled Trial SCANDIUM.

Olofsson Bagge R, Nelson A, Shafazand A, All-Eriksson C, Cahlin C, Elander N, Gustavsson A, Helgadottir H, Kiilgaard JF, Kinhult S, Ljuslinder I, Mattsson J, Rizell M, Sternby Eilard M, Ullenhag GJ, Nilsson JA, Ny L, Lindnér P. Olofsson Bagge R, et al. Among authors: helgadottir h. Ann Surg. 2024 Feb 29. doi: 10.1097/SLA.0000000000006255. Online ahead of print. Ann Surg. 2024. PMID: 38420778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page